India CGM Market Analysis
The India Continuous Glucose Monitoring Market size is estimated at USD 207.52 million in 2025, and is expected to reach USD 364.58 million by 2030, at a CAGR of 11.93% during the forecast period (2025-2030).
India is currently witnessing a notable increase in its diabetes prevalence, as the nation grapples with a rising epidemic of both type 1 and type 2 diabetes. Recent data underscores the magnitude of this issue, as India is home to one of the largest diabetic populations globally. According to the International Diabetes Federation (IDF), India is projected to have 101.2 million diabetes cases by 2030.
Continuous Glucose Monitoring is a new technology glucose monitoring device, which tracks blood glucose levels day and night. Sensor: Sensors are disposable devices placed under the skin, which measure blood glucose levels. A sensor can be used for several days before it needs to be replaced. Durables consist of transmitters and receivers. Transmitters are connected to the sensor and a reader (receiver) receives and displays the measurements. The device provides real-time measurements.
The factors that have driven the number of reported cases of diabetes can be segmented into individual-level risk factors, environmental risk factors, the evolution of the disease, detection effects, and global changes.
India CGM Market Trends
Sensors is having the highest market share in current year.
The sensors segment is expected to increase with a CAGR of over 17% during the forecast period, mainly due to the demand from the Type-1 diabetes population, which was more than 60 million by the forecast period.
The sensor device is a tiny electrode that measures glucose levels in diabetes patients. The sensors continuously measure the glucose levels in the body through a small filament that is inserted under the skin and records the glucose levels. Within 5 seconds, the users can download the data stored in the sensors. In India's continuous glucose monitoring devices market, the Free Style Libre Pro sensor (14 days working), Dexcom's G4 sensor (10 days working), Medtronic's Guardian sensor (7 days working), and the fluorescence sensor are considered.
In India, Dexcom is still selling its Dexcom G4 Platinum CGM system, whereas it is selling its Dexcom G5 and G6 CGM technologies in other countries. Dexcom planned to launch its cheaper, smaller sensors developed in partnership with Verily Life Science divisions. With the advent of low-cost CGM in the coming years and the support from the government on subsidies for diabetes monitoring devices, manufacturers of CGM devices can penetrate the high-potential market of India.
India recorded the second-highest diabetes population in Asia-Pacific in current year
Various factors contribute to the escalating diabetes rates in India. Rapid urbanization, sedentary lifestyles, poor dietary choices, and genetic predispositions are key drivers of this epidemic. Moreover, issues like obesity, high rates of gestational diabetes, and limited healthcare access in certain areas further compound the problem.
Type 2 diabetes represents the majority of diabetes cases in India, with estimates indicating that over 90% of individuals with diabetes have this type. Lifestyle factors such as obesity, lack of physical activity, and unhealthy eating habits are closely linked to type 2 diabetes, and are increasingly prevalent among both urban and rural populations in India.
The growing diabetes burden in India presents significant challenges for the healthcare system and economy. Diabetes is associated with a heightened risk of cardiovascular disease, stroke, kidney disease, and other complications, placing a substantial strain on healthcare resources and escalating costs. Tackling the diabetes epidemic necessitates comprehensive public health strategies that emphasize prevention, early detection, lifestyle changes, and equitable access to quality healthcare services for all segments of the population.
Hence, the demand for continuous glucose monitoring devices is on the rise, and their adoption rate is also increasing. These factors are expected to drive the market studied.
India CGM Industry Overview
India's continuous glucose monitoring market is highly consolidated. Manufacturers have driven constant innovation to compete in the market. The major players, such as Abbott and Medtronic, have undergone many mergers, acquisitions, and partnerships to establish market dominance.
India CGM Market Leaders
Abbott Diabetes Care Inc.
Dexcom Inc.
Medtronic PLC
Eversense
Ascensia
- *Disclaimer: Major Players sorted in no particular order
India CGM Market News
- February 2023: Dario Health Corp. announced an agreement with Dexcom to integrate its CGM, into Dario's multi-chronic condition platform. Dexcom CGM uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health. This agreement enables the integration of data from Dexcom CGMs directly into Dario's metabolic solution, making it easy for people using the wearable device to benefit from Dario's highly personalized support.
- January 2022: Health-tech startup BlueSemi, launched Eyva, a non-invasive glucometer for diabetics that can provide results without any pricking or needles. Eyva is a health tech gadget that when placed on the surface of the skin, is capable of taking six biometric readings within just 60 seconds; blood glucose, temperature, ECG, heart rate, SpO2 for blood oxygen, and blood pressure.
